EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Breast implant illness after reconstruction with silicone breast implants

Jonathan Spoor iD, Marc A M Mureau iD, Renaud L M Tissier iD, Juliëtte Hommes iD, Hinne Rakhorst iD, Mintsje de Boer, Hester S A Oldenburg iD, Esther M Heuts, Yvonne L J Vissers, Anneriet E Dassen, Daniel J Evers iD, Linetta B Koppert und 7 weitere

JNCI: Journal of the National Cancer Institute · 01.08.2025 · 117 (8) · 1717-1728

DOI: 10.1093/jnci/djaf136 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 03.07.2025. Verfasst von Jonathan Spoor und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Breast Implants, Breast Neoplasms, Mammaplasty, Silicone Gels. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Ministry of Health, Welfare and Sport, National Institute for Public Health and the Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background “Breast implant illness” (BII) is a constellation of non-specific constitutional, rheumatologic, mental, and cognitive symptoms reported increasingly by women carrying silicone breast implants (SBIs). The impact of BII on the well-being of breast cancer patients with SBI-based breast reconstructions is a subject of debate.

Methods

In a multicenter cohort of breast cancer survivors (n = 9590) treated between 2000 and 2015 in 6 major regional hospitals in the Netherlands, we performed a health survey (response rate 64.7%). The presence of 18 BII-associated symptoms was compared between patients with and without SBIs in multivariable logistic regression models. In a latent class analysis (LCA), distinct symptom patterns were identified in the study population.

Results

Median follow-up time was 13.7 (IQR, 6.8) years. Of all SBI-exposed patients (n = 1821), 20.7% reported ≥4 BII-associated symptoms vs 21.2% of non-exposed patients (risk ratio 0.98; 95% CI = 0.88 to 1.09). Joint pain, sicca, sleep impairment, morning stiffness, and shoulder pain were reported most frequently. Patients with SBIs did not have a significantly increased risk of any of the individual BII-associated symptoms. The LCA identified 5 distinct symptom clusters. Patients with SBI-exposure had a lower risk of falling in the most severe symptom cluster (odds ratio 0.64; 95% CI = 0.43 to 0.96). The other symptom clusters were not significantly associated with SBI-exposure.

Conclusions

Our results indicate that breast cancer survivors with SBI-based reconstructions do not experience more BII-associated symptoms than breast cancer survivors without SBIs, challenging the notion of BII as a distinct clinical entity based on a generic silicone-induced biomechanical pathophysiological mechanism.

Trial registration

This study was preregistered at ClinicalTrials.gov on June 2, 2022 (NCT05400954).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast ImplantsBreast NeoplasmsMammaplastySilicone GelsHumansFemaleMiddle AgedAdultNetherlandsAgedCancer SurvivorsSiliconesBreast ImplantationFollow-Up Studies

Substanzen

Silicone GelsSilicones

Autor:innen und Institutionen

  • Department of Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Biostatistics Unit, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Plastic and Reconstructive Surgery, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Department of Plastic, Reconstructive and Hand Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Department of Plastic, Reconstructive and Hand Surgery, Ziekenhuisgroep Twente, Hengelo, The Netherlands.

ORCID-Profile: Jonathan Spoor, Marc A M Mureau, Renaud L M Tissier, Juliëtte Hommes, Hinne Rakhorst, Hester S A Oldenburg, Daniel J Evers, Sabine C Linn, Daphne de Jong, Rene R W J van der Hulst, Marie-Jeanne T F D Vrancken Peeters, Eveline M A Bleiker, Flora E van Leeuwen

Förderung

  • Dutch Ministry of Health, Welfare and Sport
  • National Institute for Public Health and the Environment

Zitieren

APA

Spoor, J., Mureau, M. A. M., Tissier, R. L. M., Hommes, J., Rakhorst, H., de Boer, M., Oldenburg, H. S. A., Heuts, E. M., Vissers, Y. L. J., Dassen, A. E., Evers, D. J., Koppert, L. B., Zaal, L. H., Linn, S. C., de Jong, D., van der Hulst, R. R. W. J., Vrancken Peeters, M. T. F. D., Bleiker, E. M. A., & van Leeuwen, F. E. (2025). Breast implant illness after reconstruction with silicone breast implants. JNCI: Journal of the National Cancer Institute, 117(8), 1717-1728. https://doi.org/10.1093/jnci/djaf136

Vancouver

Spoor J, Mureau MAM, Tissier RLM, Hommes J, Rakhorst H, de Boer M, et al. Breast implant illness after reconstruction with silicone breast implants. JNCI: Journal of the National Cancer Institute. 2025;117(8):1717-1728. doi:10.1093/jnci/djaf136

BibTeX
@article{Spoor2025,
  author = {Spoor, Jonathan and Mureau, Marc A M and Tissier, Renaud L M and Hommes, Juliëtte and Rakhorst, Hinne and de Boer, Mintsje and Oldenburg, Hester S A and Heuts, Esther M and Vissers, Yvonne L J and Dassen, Anneriet E and Evers, Daniel J and Koppert, Linetta B and Zaal, Laura H and Linn, Sabine C and de Jong, Daphne and van der Hulst, Rene R W J and Vrancken Peeters, Marie-Jeanne T F D and Bleiker, Eveline M A and van Leeuwen, Flora E},
  title = {Breast implant illness after reconstruction with silicone breast implants},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  volume = {117},
  number = {8},
  pages = {1717--1728},
  doi = {10.1093/jnci/djaf136}
}
Kostenlos starten →